Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
biotech
boston blog main
9
×
boston top stories
life sciences
national blog main
national top stories
national
boston
event
life science
deals
gene therapy
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
abbvie
acetylon pharmaceuticals
adverum biotechnologies
albert bourla
alzheimer's disease
ambys medicines
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
cell therapy
What
future
9
×
accelerating
attend
biopharma's
biopharma’s
boston
breakthroughs
digital
health
learn
life
medical
registering
sciences
team
tech
xcelerating
join
online
today
acquisitions
aiming
albert
ambys
big
biggest
bio
biotech
bird
bourla
ceo
company
control
crispr
deadly
deal
debuted
diseases
drug
early
Language
unset
unknown
Current search:
future
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?